Risk of dementia following herpes zoster infection among patients undertreatment versus those not: A systematic review and meta-analysis.

This study demonstrated that antiviral therapies may significantly lower the risk of dementia in patients with HZ. This study also confirmed that patients with HZ, without receiving antiviral therapies, may have an increased risk of developing dementia. Further longitudinal research is warranted in this area.